NO932842L - 1,4-benzodioksanderivater - Google Patents

1,4-benzodioksanderivater

Info

Publication number
NO932842L
NO932842L NO932842A NO932842A NO932842L NO 932842 L NO932842 L NO 932842L NO 932842 A NO932842 A NO 932842A NO 932842 A NO932842 A NO 932842A NO 932842 L NO932842 L NO 932842L
Authority
NO
Norway
Prior art keywords
benzodioksanderivater
Prior art date
Application number
NO932842A
Other languages
English (en)
Norwegian (no)
Other versions
NO932842D0 (no
Inventor
Henning Boettcher
Christoph Seyfried
Hartmut Greiner
Gerd Bartoszyk
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO932842D0 publication Critical patent/NO932842D0/no
Publication of NO932842L publication Critical patent/NO932842L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO932842A 1992-08-11 1993-08-10 1,4-benzodioksanderivater NO932842L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4226527A DE4226527A1 (de) 1992-08-11 1992-08-11 1,4-Benzodioxanderivate

Publications (2)

Publication Number Publication Date
NO932842D0 NO932842D0 (no) 1993-08-10
NO932842L true NO932842L (no) 1994-02-14

Family

ID=6465290

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932842A NO932842L (no) 1992-08-11 1993-08-10 1,4-benzodioksanderivater

Country Status (13)

Country Link
EP (1) EP0586866A3 (fr)
JP (1) JPH06184140A (fr)
KR (1) KR940003953A (fr)
CN (1) CN1085217A (fr)
AU (1) AU4456293A (fr)
CA (1) CA2103601A1 (fr)
CZ (1) CZ159893A3 (fr)
DE (1) DE4226527A1 (fr)
HU (1) HU9302314D0 (fr)
MX (1) MX9304820A (fr)
NO (1) NO932842L (fr)
PL (1) PL300016A1 (fr)
SK (1) SK77693A3 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2595965B2 (ja) * 1987-05-11 1997-04-02 株式会社日立製作所 同報通信システム
SI0707007T1 (en) * 1994-10-14 2002-04-30 Merck Patent Gmbh (R)-(-)-2-(5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)chromane as CNS active agent
TW446706B (en) * 1995-02-07 2001-07-21 Janssen Pharmaceutica Nv Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines, a pharmaceutical composition containing them, their intermediates and a process for their preparation
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
AU1504599A (en) * 1997-12-17 1999-07-05 Shionogi & Co., Ltd. Novel pyridine compounds
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
DE10029371A1 (de) * 2000-06-20 2002-01-03 Merck Patent Gmbh Heterocyclische Aminoalkylpyridinderivate als Psychopharmaka
ATE352302T1 (de) 2001-07-26 2007-02-15 Merck Patent Gmbh Verwendung von 2- 5-(4-fluorphenyl)-3- pyridylmethylaminomethyl-chroman und seiner physiologisch annehmbaren salze
CN102675302B (zh) * 2011-03-17 2014-06-11 南京大学 含1,4-苯并二噁烷的噻二唑衍生物及其制法与其抗菌活性
CN102690261B (zh) * 2011-03-25 2015-02-25 南京大学 含1,4-苯并二噁烷的1,3,4-噁二唑衍生物的制法及其在抗癌药物中应用
CN103420989B (zh) * 2012-05-15 2016-03-23 华中科技大学 苯并二噁烷类衍生物及其应用
CN102746286B (zh) * 2012-07-25 2015-07-15 山东理工大学 苯并二噁唑及其制备方法
US9267246B2 (en) 2014-05-20 2016-02-23 Caterpillar Paving Products Inc. Paving machine having vibration-isolated screed assembly

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE613213A (fr) * 1961-01-30 1962-07-30 Geigy Ag J R Nouveaux 1.4-benzodioxannes et leur préparation
US3277090A (en) * 1962-07-16 1966-10-04 Frosst & Co Charles E 1:4-benzodioxan derivatives
GB1094982A (en) * 1963-05-08 1967-12-13 Ward Blenkinsop & Co Ltd 1,4-benzodioxanes
JPS54103893A (en) * 1978-01-26 1979-08-15 Morishita Pharma 1*44benzodioxane derivative

Also Published As

Publication number Publication date
EP0586866A3 (fr) 1994-04-13
AU4456293A (en) 1994-02-17
HU9302314D0 (en) 1993-10-28
MX9304820A (es) 1994-02-28
NO932842D0 (no) 1993-08-10
JPH06184140A (ja) 1994-07-05
CN1085217A (zh) 1994-04-13
DE4226527A1 (de) 1994-02-17
EP0586866A2 (fr) 1994-03-16
CZ159893A3 (en) 1994-03-16
CA2103601A1 (fr) 1994-02-12
SK77693A3 (en) 1994-05-11
KR940003953A (ko) 1994-03-14
PL300016A1 (en) 1994-04-05

Similar Documents

Publication Publication Date Title
FI953489A (fi) 2,6-diaminopuriinijohdannaisia
NO920018L (no) 1,3-oksatiolannukleosidanaloger
FI934610A0 (fi) Ventilsammansaettning foer roerledning, omfattande loestagbart ventilsaete
FI932516A (fi) Styrkonsol, i synnerhet foer motorfordon
NO932842L (no) 1,4-benzodioksanderivater
FI931747A (fi) Reflexkropp, isynnerhet foer vaegmarkeringar
DE59308564D1 (de) 2,4-Dialkyl-6-sec-alkylphenole
FI923709A0 (fi) I en saekerhetsskena laosbar vagn.
FI920940A0 (fi) Gasmask.
FI934317A (fi) Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen
NO944024L (no) 1,2-dihydro-2-okso-pyridin
NO922732D0 (no) 3,4-dehydropiperidinderivater
FI922100A0 (fi) Traedkvistare -kapare.
NO942212D0 (no) 13,14-dihydro-PGF2
NO943791D0 (no) 1,2-dihydro-2-okso-3-metylsulfonylaminometylpyridin
FI266U1 (fi) Kapningsanordning foer aemnesbana, saosom en pappersbana
FI935129A0 (fi) Tvaovaoningsgodsvagn, saerskilt foer biltransport
FI922527A0 (fi) Vaeggkonstruktion foer anordning i byggnader.
FI784U1 (fi) Skalkonstruktion, speciellt vaeggkonstruktion, foer byggnad
SE9202883D0 (sv) Tving, roertving
SE9203391D0 (sv) Laangstraeckt, boejbart baerelement
FI920063A0 (fi) I doerroeppning monterbar haevnings- och haengstaong.
FI923733A0 (fi) Hemligt stoldskydd i personbilar.
FI924128A0 (fi) I doerroeppningen faestbar armhaevnings- och haengstaong.
FI924217A0 (fi) Tillaempning i haevertantenn.